Osteosarcoma Clinical Trials in Memphis, Tennessee

4 studies are recruiting for osteosarcoma in Memphis, Tennessee right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

  1. Trastuzumab Deruxtecan (DS-8201a) for the Treatment of Recurrent or Refractory Osteosarcoma, Wilms Tumor, and Desmoplastic Small Round Cell Tumor

    This phase I/II trial studies the effects of trastuzumab deruxtecan (DS-8201a) in treating patients with osteosarcoma, Wilms tumor (WT) or desmoplastic small round cell tumor (DSRCT) that is newly diagnosed or has come back after a period of improvement (recurrent) or that has not responded to prev…

    Stage
    Phase 2
    Ages
    12 to 39
    Site
    Saint Jude Children's Research Hospital, Memphis, Tennessee
    Locations
    29 in total
    Run by
    National Cancer Institute (NCI)

    See if you can join NCT04616560 on ClinicalTrials.gov

  2. Thoracotomy Versus Thoracoscopic Management of Pulmonary Metastases in Patients With Osteosarcoma

    This phase III trial compares the effect of open thoracic surgery (thoracotomy) to thoracoscopic surgery (video-assisted thoracoscopic surgery or VATS) in treating patients with osteosarcoma that has spread to the lung (pulmonary metastases). Open thoracic surgery is a type of surgery done through …

    Stage
    Phase 3
    Ages
    Up to 50
    Site
    Saint Jude Children's Research Hospital, Memphis, Tennessee
    Locations
    233 in total
    Run by
    Children's Oncology Group

    See if you can join NCT05235165 on ClinicalTrials.gov

  3. Integration of Adaptive Proton Therapy in Pediatric Solid Tumors and Hodgkin's Lymphoma

    Pediatric patients receiving proton therapy for solid tumors or Hodgkin's lymphoma may experience anatomical changes during treatment that can affect proton therapy accuracy. This prospective single-arm study uses regular low-dose imaging to monitor these changes and adjust treatment plans as neede…

    Stage
    Not phased
    Ages
    Any age
    Site
    St. Jude Children's Research Hospital, Memphis, Tennessee
    Run by
    St. Jude Children's Research Hospital

    See if you can join NCT07514819 on ClinicalTrials.gov

  4. B7-H3-Specific Chimeric Antigen Receptor Autologous T-Cell Therapy for Pediatric Patients With Solid Tumors (3CAR)

    3CAR is being done to investigate an immunotherapy for patients with solid tumors. It is a Phase I clinical trial evaluating the use of autologous T cells genetically engineered to express B7-H3-CARs for patients ≤ 21 years old, with relapsed/refractory B7-H3+ solid tumors. This study will evaluate…

    Stage
    Phase 1
    Ages
    Up to 21
    Site
    St. Jude Children's Research Hospital, Memphis, Tennessee
    Run by
    St. Jude Children's Research Hospital

    See if you can join NCT04897321 on ClinicalTrials.gov

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.